Corbus Pharmaceuticals prices $75 million public offering Oct 31, 2025 02:40AM
Corbus Pharmaceuticals Announces Pricing of Public Offering Oct 31, 2025 02:40AM
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference May 8, 2025 08:00AM
Corbus Pharmaceuticals (CRBP) PT Raised to $82 at RBC Capital Jun 11, 2024 06:12AM


Jun 3, 2024 06:36AM RBC Capital Reiterates Outperform Rating on Corbus Pharmaceuticals (CRBP)
May 20, 2024 06:16AM RBC Capital Reiterates Outperform Rating on Corbus Pharmaceuticals (CRBP)
May 13, 2024 05:04AM RBC Capital Starts Corbus Pharmaceuticals (CRBP) at Outperform, 'Reinventing Themselves With Promising ADC and Obesity Assets'
May 9, 2024 08:00AM Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
May 11, 2021 08:05AM Corbus Pharmaceuticals to Present at Three Upcoming Investor Conferences
May 11, 2021 08:05AM Corbus Pharmaceuticals to Present at Three Upcoming Investor Conferences
Sep 8, 2020 11:58AM RBC Capital Downgrades Corbus Pharmaceuticals (CRBP) to Sector Perform
Jul 7, 2020 09:32AM Pre-Open Stock Movers 07/07: (NVAX) (VSLR) (RUN) Higher; (EOLS) (CLLS) (MARK) Lower (more...)
May 15, 2020 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 15, 2020 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 11, 2020 01:57PM Corbus Pharmaceuticals (CRBP) PT Lowered to $22 at RBC Capital, Positive Into Two Shots on Goal
Feb 11, 2020 04:01PM Corbus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Feb 11, 2020 04:01PM Corbus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Feb 7, 2020 09:03AM Corbus Pharma (CRBP) Prices 6.67M Share Common Offering at $6/Sh
Feb 7, 2020 09:02AM Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Feb 7, 2020 09:02AM Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Feb 6, 2020 04:56PM Corbus Pharma (CRBP) Announces Proposed Public Offering of Common Stock
Feb 6, 2020 04:01PM Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Feb 6, 2020 04:01PM Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Feb 6, 2020 04:01PM Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2019 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
May 15, 2019 08:05AM Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
Jan 30, 2019 07:30AM Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Jan 30, 2019 07:30AM Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Jan 25, 2019 09:02AM UPDATE: Corbus Pharma (CRBP) Prices 5.39M Share Common Offering at $6.50/Sh
Jan 25, 2019 09:01AM Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 25, 2019 09:01AM Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 24, 2019 04:01PM Corbus Pharma (CRBP) to Offer Common Stock
Jan 24, 2019 04:01PM Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Jan 24, 2019 04:01PM Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Dec 7, 2018 09:31AM Pre-Open Movers 12/07: (CRON) (AOBC) (AVGO) Higher; (VIVE) (BIG) (ULTA) Lower (more...)
Dec 7, 2018 06:30AM UPDATE: RBC Capital Starts Corbus Pharmaceuticals (CRBP) at Outperform
Feb 14, 2018 07:00AM Corbus Pharmaceuticals to Present at the 2018 RBC Capital Markets Global Healthcare Conference